Advanced Orthomolecular Research Targets Cardiovascular System Health with Release of Nattokinase
The new supplement promotes healthy blood flow while working to reduce risk factors for cardiovascular diseases
CALGARY, Alberta, May 29, 2019 /CNW/ -- Knowing that heart disease is Canada's second leading cause of death1 and realizing the importance of risk factor reduction, leading supplement formulator, Advanced Orthomolecular Research (AOR) has developed, Nattokinase, a new supplement that aims to greatly improve cardiovascular health for at-risk adults. Derived from the fermentation of natto, a soy-based Japanese condiment, Nattokinase is a protein-digesting molecule formulated to bolster heart health by providing enzymatic support. It works synergistically with the cardiovascular system to stimulate healthy blood flow, help break down abnormal blood clots and nasal polyps, increase hematocrit levels, and reduce risk factors for heart attack, stroke and thrombosis.
"Cardiovascular disease is now the leading cause of death in the world, and for many North Americans their risk is only amplified by obesity, smoking, high or low LDL, hypertension, inactivity, and stress," said Dr. Traj Nibber, CEO and founder of AOR. "Nattokinase protects both those who are high risk and others looking to improve their overall health."
Nattokinase helps to degrade fibrin, an insoluble protein formed by the clotting of blood that creates a fibrous mesh impeding blood flow. The supplement also influences the regulators that control blood clotting, while enhancing the activity of key enzymes that activate fibrinolysis, making it a powerful resource for those who may be at risk.
AOR's once-a-day Nattokinase capsule can be purchased through the AOR website, or at select retail locations for $29.95CAD. For more information on AOR, please visit http://www.aor.ca.
ABOUT AOR:
Advanced Orthomolecular Research (AOR), a Canadian-based company with headquarters in Calgary, Alberta, has an established reputation in Canada as the most advanced dietary supplement formulator in the country and likely, the world. AOR believes that truth and transparency are the most important values for any organization to uphold. It is through ethical discipline and evidenced-based science that they lead and advance the natural health industry. AOR seeks to catalyze change, challenge conventions through continuous innovations, and exists to create safe, effective, and therapeutic solutions.
1 "Report From The Canadian Chronic Disease Surveillance System: Heart Disease in Canada, 2018" 2018. Public Health Agency of Canada, Ottawa, ON K1A 0K9
SOURCE Advanced Orthomolecular Research (AOR)
Loren O'Neill, Telephone: 303-908-3302, Email: [email protected], https://aor.ca
Share this article